Share on LinkedInShare on LinkedIn

ARTICLE · 03 MARCH 2022

FTC Hospital Merger Challenge Signals Future Labor Market Enforcement Actions

Arnold & Porter
Arnold & Porter
Contributor
Arnold & Porter

Arnold & Porter

With over 1,000 lawyers across 16 offices worldwide, Arnold & Porter is renowned for its...

View firm profile
Explore more from Arnold & Porter

On February 17, 2022, the US Federal Trade Commission (FTC) unanimously authorized an administrative complaint and a lawsuit in US District Court for the District of Rhode Island to block the...

United StatesAntitrust/Competition Law

Introduction

On February 17, 2022, the US Federal Trade Commission (FTC) unanimously authorized an administrative complaint and a lawsuit in US District Court for the District of Rhode Island to block the proposed merger of Lifespan Corporation (Lifespan) and Care New England. The FTC's complaint asserts that the transaction would combine two of Rhode Island's largest healthcare providers and allegedly would lead to higher prices and a lower quality of care for patients in violation of Section 7 of the Clayton Act.1

The FTC's challenge to a transaction that, according to the agency, would result in one entity controlling "at least 70 percent of the Rhode Island market for inpatient general acute care hospital services and at least 70 percent of the market for inpatient behavioral health services"2 represents a traditional Section 7 theory in a hospital merger case, albeit with the FTC alleging a transaction harmed competition in the "inpatient behavioral health

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from